Investing
708 Articles
Earnings season is in full swing and the peak will occur next week. We have several DJIA components reporting earnings…
Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there…
These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Amgen Inc.…
Genzyme Corporation (NASDAQ: GENZ) still has an incredible merger ‘deal premium’ associated with it over a pending Sanofi-Aventis (NYSE: SNY)…
Genzyme Corporation (NASDAQ: GENZ) is flying high on reports that Sanofi-Aventis (NYSE: SNY) may have an interest in buying the…
Today’s version of the BioHealth Business Daily is a very unusual lot of movers. Some moves are merely in sympathy…
Sanofi-Aventis SA (NYSE: SNY) was a bit of a stalking horse news item on a week that many investors and…
There are many key movers in today’s BioHealth Business Daily. We have included background data, news, reactions, and added in…
Biotech is the land of promise for emerging players. It is also the land of stagnation for well established and…
It looks as though none of this morning’s major day trader and active trader alerts are on raw earnings announcements. …
Today’s BioHealth Business Daily has many names you might not be as familiar with, but there are some of the…
This week is a jam-packed list full of the Unusual Suspects. We have many earnings reports, enough that we had…
There are twelve major pharmaceutical firms that dominate this industry worldwide. Their combined market value is over $1 trillion with total…
Companies seemed to prefer share buybacks in 2007 and 2008, and maybe part of 2009. Why not, if the stock…
We have compiled from press releases and from company announcements a company-by-company donation and effort pledge to help in the…
Our top personal finance-related articles today. Your wallet will thank you later.